Caricamento...
Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
PURPOSE: Tyrosine kinase inhibitors like sunitinib and sorafenib are commonly used to treat metastatic renal cell cancer patients. Cubilin is a membrane protein expressed in the proximal renal tubule. Cubilin and megalin function together as endocytic receptors mediating uptake of many proteins. The...
Salvato in:
| Pubblicato in: | J Cancer Res Clin Oncol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5427164/ https://ncbi.nlm.nih.gov/pubmed/28260162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-017-2365-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|